Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Registers 2.4M Shares for Sale by Stockholders

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today filed documents with the US Securities and Exchange Commission registering 2,370,586 shares of common stock that may be sold from time to time by shareholders.

The shares were issued to the selling stockholders as part of Life Technologies' acquisition of BioTrove in November 2009.They received the shares as part of private placements in December and January.

Life Technologies will not receive any of the proceeds from the sale of the shares that have been registered for this offering.

The firm noted in the prospectus that, under terms of the merger agreement with BioTrove, Life Technologies is required to make earn-out payments to the selling stockholders if cumulative revenue related to the sale of certain assets exceeds a specified amount over the three-year period following the close of the acquisition. If the maximum earn-out is achieved, Life Technologies would issue 1,676,359 shares of common stock.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.